Evaluation of p16 expression besides HPV DNA status would be thus imperative in pre-treatment ESCC samples to differentiate between an active and a passenger HPV infection and consequent, potentially different prognosis. Here, CDKN2A is linked to esophageal squamous cell carcinoma.